Page last updated: 2024-09-03

elacridar and Sarcoma

elacridar has been researched along with Sarcoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ferry, DR; Kerr, DJ; Stevens, MC; Traunecker, HC	1

Other Studies

1 other study(ies) available for elacridar and Sarcoma

Article	Year
The acridonecarboxamide GF120918 potently reverses P-glycoprotein-mediated resistance in human sarcoma MES-Dx5 cells. British journal of cancer, 1999, Volume: 81, Issue:6 Topics: Acridines; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Isoquinolines; Sarcoma; Tetrahydroisoquinolines; Tumor Cells, Cultured	1999

Article

Year

The acridonecarboxamide GF120918 potently reverses P-glycoprotein-mediated resistance in human sarcoma MES-Dx5 cells.

British journal of cancer, 1999, Volume: 81, Issue:6

Topics: Acridines; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Isoquinolines; Sarcoma; Tetrahydroisoquinolines; Tumor Cells, Cultured

1999